The Paradigm Shift from Traditional Scientific Platforms to Integrated Communications Plans

In the rapidly evolving biopharma landscape, the approach to scientific communications is undergoing a significant transformation. The shift from traditional scientific platforms to integrated communications plans (ICPs) is becoming increasingly crucial for ensuring cohesive and impactful messaging. This article delves into the components, implementation, and benefits of an ICP tailored for the biopharma industry, addressing the challenges of fragmented messaging and the need for a unified communication strategy...
Read More

Top Stories

The Paradigm Shift from Traditional Scientific

In the rapidly evolving biopharma landscape, the approach to...
Involve Medical Affairs in insight management, early phases of clinical trials, etc.

It’s Never Too Soon: How and When to

Engagement with Medical Affairs is critical at every...
Health Literacy Month

Celebrating Health Literacy Month 2024:

October is Health Literacy Month, a reminder of the...
Image - Understanding Patient Centricity, Progress Made, and Barriers Encountered A Survey of Industry Professionals

Understanding Patient Centricity, Progress Made, and Barriers Encountered: A Survey of Industry Professionals

Cactus Life Sciences conducted a survey of pharma/biotech and associated industry professionals to gather their...
Image - What Makes Stakeholders Trust Pharma-Generated Scientific Content and How Can the Industry Do Better

What Makes Stakeholders Trust Pharma-Generated Scientific Content and How Can the Industry Do Better?

While diverse pharma stakeholders are now consuming scientific content digitally more than ever before, the...
Image - Effectiveness of Artificial Intelligence–Powered Translation Tools in Developing Medical Publications An Assessment of Japanese-to-English Translation

Effectiveness of Artificial Intelligence-Powered Translation Tools in Developing Medical Publications: An Assessment of Japanese-to-English Translation

Artificial intelligence (AI)–powered translation tools are gaining attention and acceptance to increase efficiency in medical...
Image - Understanding Patient Centricity, Progress Made, and Barriers Encountered Survey Questionnaire and Responses

Survey Report: Understanding Patient Centricity, Progress Made, and Barriers Encountered (Survey Questionnaire and Responses)

Cactus Communications commissioned a survey of pharma/biotech and associated industry professionals to understand the progress...
Racial and Ethnic Diversity in Pharma and Clinical Trials

Racial and Ethnic Diversity in Pharma and Clinical Trials

CACTUS strongly supports inclusion and diversity and is working hard to raise awareness about this...
DE&I Infographic #1

The Business Case for Diversity, Equity, and Inclusion (DE&I) in the Pharma Industry

To learn how much businesses can gain from more diverse and inclusive workplaces and why...

Learn more ABOUT our company.